LONDON (Reuters) - The Pfizer-BioNTech COVID-19 vaccine may be less able to protect against infection with a South African variant of the virus that has a worrying mutation, according to results of a British study released on Tuesday.
WASHINGTON (AP) — The Biden administration will begin providing COVID-19 vaccines to U.S. pharmacies, part of its plan to ramp up vaccinations as new and potentially more serious virus strains are starting to appear, the White House said Tuesday.
Shannon Romano, a molecular biologist, came down with Covid late last March, about a week after she and her colleagues shut down their lab at Mount Sinai Hospital. A debilitating headache came first, followed by a fever that kept rising, and then excruciating body aches. “I couldn’t sleep. I couldn’t move,” she said. “Every one of my joints just hurt inside.”
It was not an experience she wanted to repeat — ever. So when she became eligible for the Covid-19 vaccine earlier this month, she got the shot.
A little more than a third of nursing home workers have been getting COVID-19 vaccines when the shots are first offered, U.S. health officials said Monday.
Recent Comments